Andesa Financial Management’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $76.9K | Buy |
25,000
+12,500
| +100% | +$38.4K | 0.04% | 122 |
|
|
2022
Q4 | $165K | Sell |
12,500
-12,500
| -50% | -$165K | 0.09% | 140 |
|
|
2022
Q3 | $74K | Buy |
25,000
+12,500
| +100% | +$37K | 0.03% | 151 |
|
|
2022
Q2 | $46K | Hold |
12,500
| – | – | 0.03% | 133 |
|
|
2022
Q1 | $77K | Buy |
+12,500
| New | +$77K | 0.04% | 147 |
|
|
2021
Q4 | – | Sell |
-16,655
| Closed | -$248K | – | 150 |
|
|
2021
Q3 | $248K | Sell |
16,655
-16,655
| -50% | -$248K | 0.13% | 121 |
|
|
2021
Q2 | $418K | Hold |
33,310
| – | – | 0.13% | 109 |
|
|
2021
Q1 | $152K | Buy |
33,310
+16,655
| +100% | +$76K | 0.05% | 143 |
|
|
2020
Q4 | $36K | Sell |
16,655
-16,655
| -50% | -$36K | 0.02% | 117 |
|
|
2020
Q3 | $78K | Buy |
33,310
+16,655
| +100% | +$39K | 0.03% | 130 |
|
|
2020
Q2 | $33K | Hold |
16,655
| – | – | 0.03% | 114 |
|
|
2020
Q1 | $12K | Hold |
16,655
| – | – | 0.01% | 84 |
|
|
2019
Q4 | $44K | Buy |
+16,655
| New | +$44K | 0.04% | 99 |
|